GUIDE.MRD: A Consortium guiding multi-modal therapies against minimal residual disease (MRD) by liquid biopsy to assess implementation of circulating tumor DNA (ctDNA) in clinical practice to improve patient outcomes

Saved in:
Bibliographic Details
Published inANNALS OF ONCOLOGY Vol. 34; p. S276
Main Authors Pantel, K, Andersen, CL, Schuuring, E, Malats, N, Heitzer, E, Vat, L, Kiernan, E, Chin, E, Barrett, C, Kapp, R, Thomas, M, Gerling, M, Reck, M, Lohr, M, Hofman, P, Hiltermann, N, Alix-Panabieres, C, Smit, J, Bolisetty, M, Karasarides, M
Format Conference Proceeding
LanguageEnglish
Published 2023
Subjects
Medicin och hälsovetenskap
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
DOI:10.1016/j.annonc.2023.09.2960